Pramipexole as adjunct to haloperidol in schizophrenia - Safety and efficacy

Author： Kasper S.   Barnas C.   Heiden A.   Volz H.P.   Laakmann G.   Zeit H.   Pfolz H.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.7, Iss.1, 1997-02, pp. : 65-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Garcia Esther  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite

Drug safety and efficacy evaluation of sertindole for schizophrenia

By Karamatskos Evangelos   Lambert Martin   Mulert Christoph   Naber Dieter  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 1047-1062

Informa Healthcare

Access to resources Recommend Favorite

Pramipexole is a useful adjunct to mood-stabilising therapy in treatment-resistant bipolar depression

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Disturbed thermoregulation in haloperidol-treated outpatients with chronic schizophrenia

By Hermesh H.   Manaim H.   Epstein Y.   Munitz H.   Birger M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 334-334

Elsevier

Access to resources Recommend Favorite

Double-blind study of zotepine vs haloperidol in schizophrenia

By Petit M.   Raniwalla J.   Leutenegger E.   Tweed J.A.   Kelly F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 333-333

Elsevier

Access to resources Recommend Favorite